Skip to main content
Year archive

Pharming Group N.V. — 2020 filings

All 44 regulatory filings released by Pharming Group N.V. (PHARM) in 2020, sourced directly from the official regulator.

44 Filings
2020 Period
2020 filings (44)
Filing Released Lang
424B4
Prospectus
2020-12-23 English
Pharming Group announces ADSs admitted to trade on Nasdaq under the symbol "PHAR"
Capital/Financing Update
2020-12-23 English
Pharming Announces Instructions for Exchanging Listed Ordinary Shares into Nasdaq Listed ADSs
Regulatory Filings
2020-12-23 English
Regulatory Filings 2020
Regulatory Filings
2020-12-23 English
Regulatory Filings 2020
Regulatory Filings
2020-12-23 English
6-K Filing
Foreign Filer Report
2020-12-23 English
Regulatory Filings 2020
Regulatory Filings
2020-12-22 English
8A CERT
Regulatory Filings
2020-12-22 English
F-1/A
Regulatory Filings
2020-12-22 English
Regulatory Filings 2020
Regulatory Filings
2020-12-22 English
Regulatory Filings 2020
Regulatory Filings
2020-12-22 English
8-A12B
Regulatory Filings
2020-12-21 English
Regulatory Filings 2020
Regulatory Filings
2020-12-17 English
F-1/A
Regulatory Filings
2020-12-17 English
Regulatory Filings 2020
Regulatory Filings
2020-12-17 English
Regulatory Filings 2020
Regulatory Filings
2020-12-15 English
Regulatory Filings 2020
Regulatory Filings
2020-12-08 English
F-1
Regulatory Filings
2020-11-25 English
Juergen Ernst to retire from Pharming’s Board of Supervisory Directors after more than 11 years of distinguished service
Board/Management Information
2020-11-23 English
Pharming announces commitment to build a new downstream manufacturing facility for RUCONEST®
Regulatory Filings
2020-11-19 English
Pharming appoints Jeroen Wakkerman as Chief Financial Officer
Board/Management Information
2020-11-09 English
Pharming Group reports financial results for the first nine months of 2020
Interim / Quarterly Report 9M 2020
2020-10-29 English
Pharming convenes Extraordinary General Meeting of shareholders
AGM Information
2020-10-29 English
Pharming receives Orphan Drug Designation from the European Commission for leniolisib for the treatment of activated phosphoinositide 3-kinase delta syndrome (APDS)
Regulatory Filings
2020-10-21 English
Regulatory Filings 2020
Regulatory Filings
2020-10-14 English
Pharming announces the publication of data from a compassionate use programme of RUCONEST® in COVID-19 patients in a peer-reviewed journal
Regulatory Filings
2020-08-17 English
Pharming announces enrolment of first patient in multinational clinical trial for the treatment of COVID-19 with RUCONEST®
Regulatory Filings
2020-08-10 English
Interim / Quarterly Report 2020
Interim / Quarterly Report H1 2020
2020-07-30 English
Pharming Group reports financial results for the first half of 2020
Interim / Quarterly Report H1 2020
2020-07-30 English
Annual General Meeting of Shareholders
AGM Information
2020-05-21 English
Pharming Group announces the nomination of Barbara Yanni and Mark Pykett to the Board of Supervisory Directors
Board/Management Information
2020-05-20 English
Pharming celebrates “hae day :-)”
Regulatory Filings
2020-05-18 English
Pharming Group reports financial results for the first quarter of 2020
Interim / Quarterly Report Q1 2020
2020-05-14 English
Pharming receives European Commission approval for treatment of acute hereditary angioedema attacks in children with RUCONEST®
Regulatory Filings
2020-04-30 English
Pharming reports encouraging results from use of RUCONEST® in COVID-19 patients
Legal Proceedings Report
2020-04-21 English
Pharming Group convenes Annual General Meeting of shareholders
AGM Information
2020-04-08 English
Annual Report 2019
Annual Report FY 2019
2020-04-02 English
Pharming Enters the Euronext Amsterdam Midkap-index (AMX)
Regulatory Filings
2020-03-23 English
Pharming CFO to step down
Board/Management Information
2020-03-11 English
Pharming receives FDA approval of new facility for expansion of RUCONEST® production
Regulatory Filings
2020-03-09 English
Pharming Group Reports Strong Preliminary (Unaudited) Financial Results for 2019
Earnings Release FY 2019
2020-03-05 English
Pharming receives EMA approval of new facility for expansion of RUCONEST® production
Regulatory Filings
2020-01-21 English
Pharming announces the placement of €125 million senior unsecured convertible bonds due 2025
Capital/Financing Update
2020-01-15 English
Pharming announces the launch of an offering of approximately €125 million senior unsecured convertible bonds due 2025
Capital/Financing Update
2020-01-14 English